Harvard Apparatus Regenerative Technology Inc.
HRGN
$1.60
-$0.26-13.98%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 123.00K | 317.00K | 45.00K | 258.00K | 59.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 123.00K | 317.00K | 45.00K | 258.00K | 59.00K |
| Cost of Revenue | 112.00K | 302.00K | 33.00K | 175.00K | 70.00K |
| Gross Profit | 11.00K | 15.00K | 12.00K | 83.00K | -11.00K |
| SG&A Expenses | 1.08M | 1.16M | 1.10M | 1.20M | 1.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.84M | 2.15M | 1.72M | 1.62M | 1.92M |
| Operating Income | -1.71M | -1.83M | -1.67M | -1.37M | -1.86M |
| Income Before Tax | -1.70M | -1.82M | -1.66M | -1.34M | -1.86M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.70M | -1.82M | -1.66M | -1.34M | -1.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.70M | -1.82M | -1.66M | -1.34M | -1.86M |
| EBIT | -1.71M | -1.83M | -1.67M | -1.37M | -1.86M |
| EBITDA | -1.71M | -1.83M | -1.67M | -1.36M | -1.86M |
| EPS Basic | -0.10 | -0.11 | -0.10 | -0.08 | -0.12 |
| Normalized Basic EPS | -0.06 | -0.07 | -0.07 | -0.05 | -0.08 |
| EPS Diluted | -0.10 | -0.11 | -0.10 | -0.08 | -0.12 |
| Normalized Diluted EPS | -0.06 | -0.07 | -0.07 | -0.05 | -0.08 |
| Average Basic Shares Outstanding | 17.03M | 15.92M | 15.92M | 15.93M | 15.02M |
| Average Diluted Shares Outstanding | 17.03M | 15.92M | 15.92M | 15.93M | 15.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |